In the TRAVERSE trial, men with hypogonadism at high risk for CVD who received testosterone had a similar risk for major adverse cardiovascular events compared with those who received placebo. A.
Metformin did not prevent development of metabolic syndrome in men receiving androgen deprivation therapy for prostate cancer in a phase III trial. Metformin was associated with improvement in weight, ...
Testosterone propionate was once a common treatment for men with low testosterone. It’s a synthetic version of the naturally occurring hormone. This solution and other drugs that mimic testosterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback